Clinical significance of plasma VEGF value in ischemic stroke - research for biomarkers in ischemic stroke (REBIOS) study

ryu matsuo, Tetsuro Ago, Masahiro Kamouchi, Junya Kuroda, Takahiro Kuwashiro, Jun Hata, Hiroshi Sugimori, Kenji Fukuda, Seiji Gotoh, Noriko Makihara, Masayo Fukuhara, Hideto Awano, Tetsu Isomura, Kazuo Suzuki, Masahiro Yasaka, Yasushi Okada, Yutaka Kiyohara, Takanari Kitazono

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Background: Vascular endothelial growth factor (VEGF) is a well-known molecule mediating neuronal survival and angiogenesis. However, its clinical significance in ischemic stroke is still controversial. The goal of this study was to examine the temporal profile of plasma VEGF value and its clinical significance in ischemic stroke with taking its subtypes into consideration.Methods: We prospectively enrolled 171 patients with ischemic stroke and age- and gender-matched healthy subjects. The stroke patients were divided into 4 subtypes: atherothrombotic infarction (ATBI, n = 34), lacunar infarction (LAC, n = 45), cardioembolic infarction (CE, n = 49) and other types (OT, n = 43). Plasma VEGF values were measured as a part of multiplex immunoassay (Human MAP v1.6) and we obtained clinical information at 5 time points (days 0, 3, 7, 14 and 90) after the stroke onset.Results: Plasma VEGF values were significantly higher in all stroke subtypes but OT than those in the controls throughout 90 days after stroke onset. There was no significant difference in the average VEGF values among ATBI, LAC, and CE. VEGF values were positively associated with neurological severity in CE patients, while a negative association was found in ATBI patients. After adjustment for possible confounding factors, plasma VEGF value was an independent predictor of poor functional outcome in CE patients.Conclusions: Although plasma VEGF value increases immediately after the stroke onset equally in all stroke subtypes, its significance in functional outcome may be different among the stroke subtypes.

Original languageEnglish
Article number32
JournalBMC neurology
Volume13
DOIs
Publication statusPublished - Apr 8 2013

Fingerprint

Vascular Endothelial Growth Factor A
Biomarkers
Stroke
Research
Infarction
Lacunar Stroke
Immunoassay
Healthy Volunteers

All Science Journal Classification (ASJC) codes

  • Clinical Neurology

Cite this

Clinical significance of plasma VEGF value in ischemic stroke - research for biomarkers in ischemic stroke (REBIOS) study. / matsuo, ryu; Ago, Tetsuro; Kamouchi, Masahiro; Kuroda, Junya; Kuwashiro, Takahiro; Hata, Jun; Sugimori, Hiroshi; Fukuda, Kenji; Gotoh, Seiji; Makihara, Noriko; Fukuhara, Masayo; Awano, Hideto; Isomura, Tetsu; Suzuki, Kazuo; Yasaka, Masahiro; Okada, Yasushi; Kiyohara, Yutaka; Kitazono, Takanari.

In: BMC neurology, Vol. 13, 32, 08.04.2013.

Research output: Contribution to journalArticle

matsuo, R, Ago, T, Kamouchi, M, Kuroda, J, Kuwashiro, T, Hata, J, Sugimori, H, Fukuda, K, Gotoh, S, Makihara, N, Fukuhara, M, Awano, H, Isomura, T, Suzuki, K, Yasaka, M, Okada, Y, Kiyohara, Y & Kitazono, T 2013, 'Clinical significance of plasma VEGF value in ischemic stroke - research for biomarkers in ischemic stroke (REBIOS) study', BMC neurology, vol. 13, 32. https://doi.org/10.1186/1471-2377-13-32
matsuo, ryu ; Ago, Tetsuro ; Kamouchi, Masahiro ; Kuroda, Junya ; Kuwashiro, Takahiro ; Hata, Jun ; Sugimori, Hiroshi ; Fukuda, Kenji ; Gotoh, Seiji ; Makihara, Noriko ; Fukuhara, Masayo ; Awano, Hideto ; Isomura, Tetsu ; Suzuki, Kazuo ; Yasaka, Masahiro ; Okada, Yasushi ; Kiyohara, Yutaka ; Kitazono, Takanari. / Clinical significance of plasma VEGF value in ischemic stroke - research for biomarkers in ischemic stroke (REBIOS) study. In: BMC neurology. 2013 ; Vol. 13.
@article{e2e19846e356469e82b9164a8cac3ce4,
title = "Clinical significance of plasma VEGF value in ischemic stroke - research for biomarkers in ischemic stroke (REBIOS) study",
abstract = "Background: Vascular endothelial growth factor (VEGF) is a well-known molecule mediating neuronal survival and angiogenesis. However, its clinical significance in ischemic stroke is still controversial. The goal of this study was to examine the temporal profile of plasma VEGF value and its clinical significance in ischemic stroke with taking its subtypes into consideration.Methods: We prospectively enrolled 171 patients with ischemic stroke and age- and gender-matched healthy subjects. The stroke patients were divided into 4 subtypes: atherothrombotic infarction (ATBI, n = 34), lacunar infarction (LAC, n = 45), cardioembolic infarction (CE, n = 49) and other types (OT, n = 43). Plasma VEGF values were measured as a part of multiplex immunoassay (Human MAP v1.6) and we obtained clinical information at 5 time points (days 0, 3, 7, 14 and 90) after the stroke onset.Results: Plasma VEGF values were significantly higher in all stroke subtypes but OT than those in the controls throughout 90 days after stroke onset. There was no significant difference in the average VEGF values among ATBI, LAC, and CE. VEGF values were positively associated with neurological severity in CE patients, while a negative association was found in ATBI patients. After adjustment for possible confounding factors, plasma VEGF value was an independent predictor of poor functional outcome in CE patients.Conclusions: Although plasma VEGF value increases immediately after the stroke onset equally in all stroke subtypes, its significance in functional outcome may be different among the stroke subtypes.",
author = "ryu matsuo and Tetsuro Ago and Masahiro Kamouchi and Junya Kuroda and Takahiro Kuwashiro and Jun Hata and Hiroshi Sugimori and Kenji Fukuda and Seiji Gotoh and Noriko Makihara and Masayo Fukuhara and Hideto Awano and Tetsu Isomura and Kazuo Suzuki and Masahiro Yasaka and Yasushi Okada and Yutaka Kiyohara and Takanari Kitazono",
year = "2013",
month = "4",
day = "8",
doi = "10.1186/1471-2377-13-32",
language = "English",
volume = "13",
journal = "BMC Neurology",
issn = "1471-2377",
publisher = "BioMed Central",

}

TY - JOUR

T1 - Clinical significance of plasma VEGF value in ischemic stroke - research for biomarkers in ischemic stroke (REBIOS) study

AU - matsuo, ryu

AU - Ago, Tetsuro

AU - Kamouchi, Masahiro

AU - Kuroda, Junya

AU - Kuwashiro, Takahiro

AU - Hata, Jun

AU - Sugimori, Hiroshi

AU - Fukuda, Kenji

AU - Gotoh, Seiji

AU - Makihara, Noriko

AU - Fukuhara, Masayo

AU - Awano, Hideto

AU - Isomura, Tetsu

AU - Suzuki, Kazuo

AU - Yasaka, Masahiro

AU - Okada, Yasushi

AU - Kiyohara, Yutaka

AU - Kitazono, Takanari

PY - 2013/4/8

Y1 - 2013/4/8

N2 - Background: Vascular endothelial growth factor (VEGF) is a well-known molecule mediating neuronal survival and angiogenesis. However, its clinical significance in ischemic stroke is still controversial. The goal of this study was to examine the temporal profile of plasma VEGF value and its clinical significance in ischemic stroke with taking its subtypes into consideration.Methods: We prospectively enrolled 171 patients with ischemic stroke and age- and gender-matched healthy subjects. The stroke patients were divided into 4 subtypes: atherothrombotic infarction (ATBI, n = 34), lacunar infarction (LAC, n = 45), cardioembolic infarction (CE, n = 49) and other types (OT, n = 43). Plasma VEGF values were measured as a part of multiplex immunoassay (Human MAP v1.6) and we obtained clinical information at 5 time points (days 0, 3, 7, 14 and 90) after the stroke onset.Results: Plasma VEGF values were significantly higher in all stroke subtypes but OT than those in the controls throughout 90 days after stroke onset. There was no significant difference in the average VEGF values among ATBI, LAC, and CE. VEGF values were positively associated with neurological severity in CE patients, while a negative association was found in ATBI patients. After adjustment for possible confounding factors, plasma VEGF value was an independent predictor of poor functional outcome in CE patients.Conclusions: Although plasma VEGF value increases immediately after the stroke onset equally in all stroke subtypes, its significance in functional outcome may be different among the stroke subtypes.

AB - Background: Vascular endothelial growth factor (VEGF) is a well-known molecule mediating neuronal survival and angiogenesis. However, its clinical significance in ischemic stroke is still controversial. The goal of this study was to examine the temporal profile of plasma VEGF value and its clinical significance in ischemic stroke with taking its subtypes into consideration.Methods: We prospectively enrolled 171 patients with ischemic stroke and age- and gender-matched healthy subjects. The stroke patients were divided into 4 subtypes: atherothrombotic infarction (ATBI, n = 34), lacunar infarction (LAC, n = 45), cardioembolic infarction (CE, n = 49) and other types (OT, n = 43). Plasma VEGF values were measured as a part of multiplex immunoassay (Human MAP v1.6) and we obtained clinical information at 5 time points (days 0, 3, 7, 14 and 90) after the stroke onset.Results: Plasma VEGF values were significantly higher in all stroke subtypes but OT than those in the controls throughout 90 days after stroke onset. There was no significant difference in the average VEGF values among ATBI, LAC, and CE. VEGF values were positively associated with neurological severity in CE patients, while a negative association was found in ATBI patients. After adjustment for possible confounding factors, plasma VEGF value was an independent predictor of poor functional outcome in CE patients.Conclusions: Although plasma VEGF value increases immediately after the stroke onset equally in all stroke subtypes, its significance in functional outcome may be different among the stroke subtypes.

UR - http://www.scopus.com/inward/record.url?scp=84875847974&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875847974&partnerID=8YFLogxK

U2 - 10.1186/1471-2377-13-32

DO - 10.1186/1471-2377-13-32

M3 - Article

VL - 13

JO - BMC Neurology

JF - BMC Neurology

SN - 1471-2377

M1 - 32

ER -